Mangoceuticals (MGRX) Return on Sales (2023 - 2026)

Mangoceuticals has disclosed Return on Sales across 4 years of filings, most recently posting 0.5% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.5%, down 6.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.46% (down 24.0% YoY), and the FY2025 annual result was 0.45%, down 31.0% from the prior year.
• Return on Sales came in at 0.5% for Q1 2026 at Mangoceuticals, down from 0.29% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.07% in Q3 2023 to a low of 0.9% in Q3 2025.
• The 4-year median for Return on Sales is 0.19% (2024), against an average of 0.28%.
• Across the five-year window, Return on Sales climbed 14 bps in 2024 and plunged 75 bps in 2025, its largest moves.
• Mangoceuticals' Return on Sales stood at 0.11% in 2023, then slumped by 76 bps to 0.19% in 2024, then sank by 59 bps to 0.29% in 2025, then tumbled by 71 bps to 0.5% in 2026.
• The last three Return on Sales figures came in at 0.5% (Q1 2026), 0.29% (Q4 2025), and 0.9% (Q3 2025), per Business Quant data.